-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efzofitimod in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efzofitimod in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efzofitimod in Systemic Sclerosis (Scleroderma) Drug Details: efzofitimod (ATYR-1923) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efzofitimod in Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efzofitimod in Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efzofitimod in Interstitial Lung Diseases (Diffuse Parenchymal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Alequel in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Alequel in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alequel in Crohn's Disease (Regional Enteritis) Drug Details: Alequel is...
-
Product Insights
Huntington Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Huntington Disease - Drugs In Development, 2023’, provides an overview of the Huntington Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Huntington Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Medical Imaging Information Systems Pipeline Market Report Overview Medical imaging information systems are used in hospitals and diagnostic imaging centers to store, retrieve, modify, and forward images and information to hospital departments or imaging centers over a network. The Medical Imaging Information Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Other Colorectal Cancer Screening Tests ·       Fecal DNA Test Kits ·       Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories ·       The US ·       Europe...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efzofitimod in Pulmonary Sarcoidosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Efzofitimod in Pulmonary Sarcoidosis Drug Details: efzofitimod (ATYR-1923) is under development for the treatment of...
-
Company Profile
Petco Health and Wellness Co Inc – Company Profile
Petco Health and Wellness Co Inc (Petco) is a health and wellness company. Its product range includes dry and wet food, biscuits and treats, vitamins and supplements, bones and chews. It also offers accessories such as clothes, beds, bowls and feeders, collars, leashes and harnesses, crates and kennels for dogs, cats, reptiles and birds. Petco services include grooming, veterinary services, dog training, insurance, pet adoption, and shipping and delivery, among others. The company markets its products under the brands Wholehearted,...
Add to Basket -
Sector Analysis
Latin America and the Caribbean Hydrogen Market Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Latin America and the Caribbean Hydrogen Market Overview Latin America and the Caribbean (LAC) currently has a low standing in the global hydrogen market. However, the region has picked up momentum with many projects in the feasibility stage. The environmental conditions across Latin America and the Caribbean (LAC) create the opportunity for a vast array of renewable resources that can be harnessed for green hydrogen production, including wind, solar, biomass, and hydropower. Â Brazil, Chile, Panama, and Argentina have the most...
-
Company Profile
Logicbio Therapeutics Inc – Company Profile
Logicbio Therapeutics Inc (Logicbio), a subsidiary of AstraZeneca Plc, is a genome-editing company with a focus on the development of transformative medicines for the treatment of hematological and genetic disorders. The company’s technology platforms include GeneRide and sAAVy™. Logicbio Generide uses to repair natural DNA cells for correct gene integration of patient chromosomes and SAAVy uses in older-generation gene therapeutics to enhance potency and tissue tropism with the potential to increase safety. The company operates in the US. Logicbio is...
Add to Basket